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| INTRODUC TI ON
Iron is an essential element of the body. However, its iron(II) species 1, [6] [7] [8] [9] Among the transition metals associated with AD pathology, including iron, copper, and zinc, iron is the most abundant in the healthy brain for normal brain function. On the other hand, iron accumulation and oxidative stress are shown as early events in AD, and the presence of elevated levels of redox-active iron has been suggested as a potential event in triggering amyloid-β (Aβ) aggregation and oxidative damage of the brain. 10 Furthermore, ferroptosis, a recently recognized iron-dependent programmed cell death, is not only caused by the accumulation of lipid-based ROS, but also suggested as the main driver of neurological cell death in diseases such as AD and PD. [11] [12] [13] [14] [15] Therefore, a better understanding of the roles of iron and the oxidizing species (generated by iron) in oxidative stress and AD is essential for developing pharmaceutical interventions to | 83 ZHAO treat neurodegenerative diseases. In this review, we examine the role of iron species in generating the most oxidatively deleterious ROS (ie, • OH) and describe the oxidative damages caused by this free radical and its consequence of inducing oxidative stress. We also discuss the association of oxidative stress with AD and the potential therapeutic strategy for this disease.
| IRON -INDUCED G ENER ATI ON OF OXID IZING S PECIE S

| Generation of the hydroxyl radical from Fenton/Fenton-like reactions
In aqueous solutions, the hydroxyl radical can be generated by the It has been proposed that in addition to hydroxyl radical, an iron(IV) species may also be generated from the Fenton or Fenton-like reactions. 2,3 However, the formation of this species from a Fenton reaction was confirmed recently only in aqueous solution 18 and its biological relevance has not been proven. Furthermore, we have recently demonstrated convincing nuclear magnetic resonance spectroscopyevidence that the oxidizing species generated from the Fenton-like reaction of iron(II)-citrate with hydrogen peroxide is hydroxyl radical rather than the iron(IV) species. 19 Therefore, in this review regarding the oxidizing species generated from Fenton/Fenton-like reactions, we focus on hydroxyl radical rather than the iron(IV) species.
| Iron species engaged in Fenton-like reactions in vivo
The participation of iron species in Fenton and Fenton- Furthermore, lysosomes also contain a redox-active iron pool derived from macromolecules and cellular organelles rich in iron, such as ferritin and mitochondria. 2, 31 One of the possible sources of intracellular redox-active iron is degradation of ferritin inside lysosomes during the process of autophagy. 32 The hydrogen peroxide diffused into lysosomes may react with the iron species through the Fenton and Fenton-like reactions, which results in generation of hydroxyl radicals. 
| HYDROX YL R ADIC AL C AUS ED OXIDATIVE DAMAG E TO B I OMOLECULE S
The ROS is a general term for several radical and non-radical species, including singlet oxygen, superoxide radical, hydrogen peroxide, and hydroxyl radical. 20 Singlet oxygen is not found in animals 20 and thus it is not directly relevant to neurodegenerative diseases. Superoxide radical is a mild reductant and hydrogen peroxide is also a relatively stable species. 2,20 Therefore, we focus on the hydroxyl radical in this article.
We have noticed that because hydroxyl radical can react with many molecules at diffusion-controlled rates, the attacks by hydroxyl radicals have been suggested to be non-selective and less damaging at the crucial sites of biomolecules. However, it should be pointed out that these non-selective attacks can rapidly generate other radical species that can subsequently react with oxygen molecules to form peroxyl radicals, and these radicals can selectively induce oxidative damage to biomolecules, such as peroxidation of proteins. 4 Furthermore, a recent study has demonstrated that hydroxyl radicals produced from Fenton reaction can cause localized attacks in the nuclear DNA. 33 Therefore, the deleterious power of hydroxyl radical in causing oxidative damages to biomolecules should not be overlooked.
| Oxidative damage of DNA and RNA caused by hydroxyl radical
Hydroxyl radical can cause oxidative damage to all components of DNA, including all bases and the deoxyribose backbone. 2 This
(1)
damage can result in permanent modifications of the DNA and thus further lead to mutagenesis, carcinogenesis, and aging. 34 It has been demonstrated that the damage caused by hydroxyl radical from the Fenton reaction is localized in the nuclear DNA. These site-specific attacks to DNA are mainly induced by additions of hydroxyl radical to the double bond at C4 of the adenosine in nuclear DNA. 33 The oxidation of DNA and RNA caused by hydroxyl radical can be detected by using the 8-hydroxy-2-deoxyguanosine (8OHdG) and 8-hydroxyguanosine (8OHG) as markers, respectively. 35 The increased level of 8OHG has been found in the neuronal perikaryal cytoplasm and this is relevant to neurofibrillary tangles, a hallmark lesion of AD. 
| Oxidative damage of lipids and proteins caused by hydroxyl radical
Hydroxyl radical can react with biomolecules by hydrogen abstraction and hydroxyl addition to form other radical species that can subsequently react with oxygen molecules to form peroxyl radicals.
These peroxyl radicals can cause lipid peroxidation of membranes and protein peroxidation. 4 Lipid peroxidation can be demonstrated by altered phospholipid composition and several markers, such as thiobarbituric acid reactive substances, malondialdehydes, 4-hydroxy-2-transnonenal, and isoprostane, which indicates altered membrane integrity. 
| IRON AND OXID IZING S PECIE S IN OXIDATIVE S TRE SS AND AD
| Sources of redox-active iron species in AD
Because iron accumulation and oxidative stress have been shown as early events in AD, the presence of elevated levels of redox-active iron could be a key factor in causing Aβ aggregation and oxidative damage in the disease. 10 However, the precise source of redox-active iron integrated into amyloid plaque cores is not known. Multiple sources of iron may be engaged in the amyloid-iron interaction in AD, such as ferritin, transferrin, and the labile iron pool. 
| Recently recognized cell death pathway associated with iron, oxidizing species, and AD
Ferroptosis is a recently recognized form of iron-dependent programmed cell death that is caused by the accumulation of lipid-based ROS. 11, 13 For decades before ferroptosis was recognized, brain cell death has been attributed to apoptosis or necrosis. 40 However, ferroptosis cannot be prevented by well-known small-molecule inhibitors of apoptosis, necrosis, or autophagy. 31 With the accumulation of evidences correlating elevated iron levels and increased lipid peroxidation in the brains of AD patients to the pathological processes, ferroptosis has now been suggested as the main driver of neurological cell death in AD. 11, 12, 14, 15 Although the exact role of iron in ferroptosis remains elusive, one possible underlying mechanism is the Fenton and Fenton-like reactions of iron species with lipid peroxides to produce oxidative radical species (see . 41 This hypothesis is supported by the evidence that ferroptosis can be prevented by lipophilic antioxidants, such as vitamin E, and by iron chelators, including deferoxamine. 31 Ferroptotic death is often correlated to the disruption of iron homeostasis, resulting in an increased level of redox-active iron, in particular the iron(II) species. 11 Interestingly, study has shown recently that deleting mitochondria from cells does not prevent ferroptosis, indicating that ferroptotic death does not need mitochondria.
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| S TR ATEG IE S TO COMBAT AD
| Iron chelation for treatment of AD
The presence of elevated levels of redox-active iron has been suggested as a potential event causing Aβ aggregation and oxidative damage of the brain. 10 Thus, therapeutic interventions with iron chelators that target iron metabolism have been developed. For instance, the iron chelator deferiprone can cross the blood-brain barrier and reduce the abnormally high concentration of cerebral iron in the brain. 43 However, to date, treatments of neurodegenerative diseases by iron-chelating agents have not demonstrated compelling clinical effect. 43 The failures may be due to lack of specificity leading to depletion of iron stores and other essential metals required for maintaining neuronal health.
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| Antioxidants for treatment of AD
Targeted antioxidant is an emerging strategy to combat the deleterious effects of ROS, in which small molecules that preferentially scavenge ROS at specific intracellular sites are designed or identified. For inhibiting the ferroptosis, several potential antioxidants have been developed or discovered. For instance, a small molecule, ferrostatin-1, was synthesized as an inhibitor of ferroptosis and it can also prevent glutamate toxicity in rat hippocampal slice cultures. 31, 51 In addition, vitamin E has been suggested as an inhibitor of lipoxygenase and subsequently inhibits ferroptosis. 11 CoQ10, an endogenously produced lipid-soluble antioxidant, has been shown to reduce the oxidative damage of proteins, lipids, and DNA caused by ROS. 52 The potential role CoQ10 in reducing ferroptotic death deserves further investigation. However, exogenously supplemented vitamin E and CoQ10 tend to be retained in cell membranes due to their lipophilic nature. Thus, it is difficult for these supplemented compounds to achieve the intracellular concentrations of pharmacological significance. 
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